The Baldwin Insurance Group, Inc. — operating under the brand name The Baldwin Group — is an independent insurance distribution firm headquartered in Tampa, Florida. Formerly known as BRP Group, Inc., the company rebranded in May 2024 and trades on the NASDAQ under the ticker BWIN. The firm delivers tailored insurance and risk management solutions across three operating segments: Insurance Advisory Solutions (commercial risk management, employee benefits, and private risk management for businesses and high-net-worth individuals), Underwriting, Capacity & Technology Solutions (including its MGA platform MSI, reinsurance brokerage Juniper Re, and captive management), and Mainstreet Insurance Solutions (personal, commercial, and life and health products distributed through community-based channels). Representing more than three million clients across the United States, Baldwin has built a scalable, technology-enabled platform that combines organic growth with strategic acquisitions — most notably the January 2026 merger with CAC Group, a specialty and middle-market brokerage that significantly expanded the company's capabilities in property and casualty, personal lines, and employee benefits.
BWIN shares delivered a dramatic rally over the last 30 days, climbing approximately 50.7% from a closing price of $18.13 on June 12 to $27.32 as of July 13. The move was punctuated by an explosive single-day surge on June 18, when shares jumped roughly 16.8% on volume exceeding 6.1 million shares — more than three times the daily average — following news that the company had retained advisers to evaluate strategic alternatives including a potential take-private transaction. The rally continued through the end of June and into July, supported by a cascade of analyst upgrades and rising institutional interest. Over the last quarter, BWIN has gained approximately 13.7%, moving from $24.03 in mid-April to the current level. The quarterly trend tells a story of early spring weakness — shares fell as low as $18.13 by mid-June — followed by the sharp late-quarter recovery fueled by strategic speculation and improving sentiment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The primary catalyst for BWIN's 30-day surge was the June 18 disclosure that the insurance brokerage is exploring strategic options, including a potential take-private deal backed by private equity. This immediately reframed the investment narrative, as insurance brokerages generate recurring, contractual commission revenue and operate with low capital requirements — precisely the profile that attracts private equity buyers who can deploy leverage in ways public markets constrain. JPMorgan analyst Pablo Singzon followed the news on June 22 with an upgrade to Overweight from Neutral, raising the price target to $28 from $25 and describing a take-private as a "credible enough outcome" that could crystallize value. JPMorgan subsequently raised its target again to $30 on July 13. The analyst wave was broad: Morgan Stanley set a $28 target, BMO Capital raised its target to $25, and Keefe Bruyette & Woods lifted its target to $31 with an Outperform rating on July 8. Additionally, Artisan Partners disclosed a new position in early June, voicing confidence in Baldwin's business model and its resilience to AI-driven disruption. The company's Q1 2026 results — $532.2 million in revenue (up 29% year-over-year), adjusted EBITDA of $137.2 million (up 21%), and rapid synergy realization from the CAC Group acquisition — reinforced the fundamental case even as the strategic review captured headlines.
BWIN's quarterly performance was shaped by two distinct phases. Through April and May, the stock trended lower amid concerns about margin compression, elevated leverage of approximately 4.3x net debt to EBITDA, and modest organic revenue growth of roughly 2% in Q1 2026 — excluding the contribution from newly acquired partnerships. A significant insider sale by major shareholder Elizabeth Krystyn of 130,018 shares at $21.20 on May 7 added to near-term selling pressure. Sentiment began to shift in early June following TD Cowen's reiterated Buy rating and $37 price target, which named BWIN its 2026 small- to mid-cap top pick and highlighted the stock's discounted valuation at 7.2 times 2027 estimated earnings versus a peer average of roughly 14 times. The William Blair Growth Stock Conference presentation on June 3 also provided management an opportunity to articulate the company's growth roadmap. The take-private exploration news in mid-June then served as the decisive turning point, transforming the quarterly performance from negative territory into positive gains and setting the stage for sustained upward momentum into July.
In dynamic markets, identifying timely opportunities can be challenging — which is where Tickeron's Trending AI Robots page offers a data-driven resource that I find useful in my own workflow. Tickeron hosts hundreds of AI-powered trading bots that actively trade thousands of tickers across various strategies, timeframes, and market conditions. However, only the top-performing and most relevant bots rise to the Trending section — a curated display designed to highlight strategies that are currently resonating with real-time market dynamics. These bots employ diverse methodologies, from swing trading and trend-following to breakout and pattern-recognition approaches, each with distinct risk and performance profiles. For traders and investors seeking systematic, algorithm-driven insights, exploring the Trending AI Robots page can provide a practical entry point into AI-assisted decision-making. I have used this resource to cross-check momentum signals around names like BWIN when strategic developments emerge. Visit the Trending AI Robots page to discover which strategies are capturing attention right now.
The most immediate event on BWIN's calendar is the company's second-quarter 2026 earnings report, scheduled for July 30, 2026. Analysts will be closely watching organic revenue growth trends, margin trajectory, progress on the CAC Group integration — including cross-sell execution and further synergy realization — and any updates on the strategic review process. Management previously guided for Q2 revenue of $485 million to $490 million and mid-single-digit organic growth, with acceleration expected in the second half of the year. Beyond earnings, investors should monitor developments around the potential take-private transaction, as any formal offer or termination of the strategic review would likely drive significant price action. Macroeconomic factors — including interest rate expectations, commercial insurance pricing cycles, and credit market conditions — will also influence both Baldwin's operating environment and the feasibility of any leveraged buyout. The company's $250 million share repurchase authorization, with approximately $203 million remaining, represents an additional source of potential demand for shares, though buybacks may be deprioritized if a take-private process advances.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
BWIN broke above its upper Bollinger Band on June 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 42 similar instances where the stock broke above the upper band. In of the 42 cases the stock fell afterwards. This puts the odds of success at .
The 10-day RSI Indicator for BWIN moved out of overbought territory on July 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where BWIN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWIN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BWIN entered a downward trend on June 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on June 18, 2026. You may want to consider a long position or call options on BWIN as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BWIN just turned positive on June 18, 2026. Looking at past instances where BWIN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
BWIN moved above its 50-day moving average on June 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BWIN crossed bullishly above the 50-day moving average on June 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWIN advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BWIN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.763) is normal, around the industry mean (6.475). P/E Ratio (0.000) is within average values for comparable stocks, (29.805). BWIN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.750). BWIN's Dividend Yield (0.000) is considerably lower than the industry average of (0.014). P/S Ratio (1.272) is also within normal values, averaging (3.406).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BWIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows